dermatology

Views & Analysis
eye-on-innovation-16x9-18_07_2018

The sky’s the limit for LEO Pharma's R&D hub

As part of pharmaphorum’s eye-on-innovation series of interviews, Richard Staines speaks to Michael Sierra, Vice President of LEO Pharma’s Science and Tech Hub, about how the firm plans to chan

News
French pharma company Sanofi

FDA to review Sanofi's Dupixent in asthma

The FDA is to review Sanofi/Regeneron's Dupixent as a treatment for asthma, a new use that could more than double its sales following its previous approval for eczema.